| __timestamp | Alpine Immune Sciences, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 9079000 |
| Thursday, January 1, 2015 | 6844000 | 20309000 |
| Friday, January 1, 2016 | 8586000 | 16945000 |
| Sunday, January 1, 2017 | 6079000 | 20559000 |
| Monday, January 1, 2018 | 8362000 | 29641000 |
| Tuesday, January 1, 2019 | 9467000 | 88258000 |
| Wednesday, January 1, 2020 | 10899000 | 162170000 |
| Friday, January 1, 2021 | 14560000 | 167218000 |
| Saturday, January 1, 2022 | 17968000 | 239528000 |
| Sunday, January 1, 2023 | 22222000 | 94252000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, effective cost management is crucial for sustaining innovation and growth. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Galapagos NV from 2014 to 2023. Over this period, Alpine Immune Sciences saw a nearly tenfold increase in SG&A expenses, peaking at $22 million in 2023. Meanwhile, Galapagos NV experienced a more volatile trajectory, with expenses surging to $239 million in 2022 before dropping to $94 million in 2023. This fluctuation highlights the challenges and strategic decisions faced by biotech firms in managing operational costs. Understanding these trends provides valuable insights into the financial strategies of these companies, offering a window into their operational priorities and market positioning.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Galapagos NV
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Selling, General, and Administrative Costs: AstraZeneca PLC vs Galapagos NV
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Comparing SG&A Expenses: Alkermes plc vs Alpine Immune Sciences, Inc. Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Veracyte, Inc.
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV
Breaking Down SG&A Expenses: Mesoblast Limited vs Galapagos NV
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV